Given the nature of the product and the route of administration, no problems of overdosage are expected as the excess fluid will flow from the eye. A toxicology study following topical ocular administration of VISLUBE multi, conducted in the rabbit, showed that overdosing with VISLUBE multi did not result in any clinical or histological adverse events.